drugset / Trial / NCT01094704

Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis

NCT01094704

RandomizedParallel-groupOpen-labelBasic science

Summary

Direct measurement of mucociliary and cough clearance (MCC/CC) has been used as a biomarker in cystic fibrosis (CF). Additional knowledge of the performance of this biomarker is needed to inform exploratory clinical trial design in support of programs to develop new inhaled therapies for CF. We hypothesize that MCC/CC measurements can be used to determine the durability of action of agents like hypertonic saline (HS) which increase epithelial lining fluid height.

Timeline

Start
2009-11
Primary completion
2010-05
Completion
2010-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 4 ml Inhaled
Subject sodium chloride Unknown 7 % Inhaled

Indications